I
Inhibrx D
D
INBX
12.480
USD
-0.29
(-2.23%)
مغلق
حجم التداول
1,818
الربح لكل سهم
-4
العائد الربحي
-
P/E
0
حجم السوق
180,659,282
المقالات
العنوان: Inhibrx Biosciences Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.